ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 552

Disability in Early Rheumatoid Arthritis, Course and Predictors  

Therese Hansson1,2, Christina Book1,2, Lennart T.H. Jacobsson1,3 and Carl Turesson1,2, 1Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 2Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, 3Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disability, Health Assessment Questionnaire, Prognostic factors and rheumatoid arthritis (RA), Rheumatoid Factor

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Patient reported outcome measures (PROMs), including the Health Assessment Questionnaire Disability Index (HAQ-DI), are valuable and reliable instruments for assessment of disease severity and disability in patient with early rheumatoid arthritis (RA), and have also been reported to have prognostic value. The aim of this study was to evaluate how disability varies over time in patients with early RA, and to identify early predictors of future disability in RA.  

Methods: An inception cohort of patients with early RA (symptom duration ≤12 months), recruited in Malmö in 1995-2005, was followed in a structured program, including clinical evaluation and PROMs. Changes in HAQ-DI between different time points were assessed using the paired T-test. Potential predictors of moderate/severe disability (HAQ-DI >1.0) at 5 years were examined using logistic regression.  

Results: A total of 233 patients (70 % women; mean age at diagnosis 60.5 years; 62 % RF positive; 57 % anti-CCP positive) were included. The median duration of symptoms at onset was 7 months. The median HAQ-DI score decreased from inclusion to 6 months (median 0.88 vs. 0.50; p<0.001), remained stable at 12 and 24 months, and then increased significantly again at 5 years (median 0.69; p=0.002 vs 24 months) and 10 years (median 0.75; p=0.004 vs 5 years). Baseline characteristics that predicted moderate to severe disability included high HAQ-DI scores [age-sex adjusted odds ratio (OR) 3.43 per unit; 95% confidence interval (CI) 1.88-6.27)] and high scores for pain and patient´s global assessment, but not laboratory markers of inflammation (Table). Patients with RF positive RA had a lower probability of a HAQ-DI >1 after five years (Table). Although RF negative patients were slightly older at diagnosis (mean 61.9 vs. 59.5 years) and had higher baseline HAQ scores (median 0.88 vs 0.75; p=0.09), there was a trend towards a negative association with 5-year moderate/severe disability also in analysis adjusted for age, sex and baseline HAQ-DI (OR 0.50; 95 % CI 0.23-1.07).    

Conclusion: Disability decreased early in the disease course, and thereafter increased consistently from two years after diagnosis and onwards. The latter may be related to chronic joint damage and increasing age. Moderate to severe disability after 5 years was predicted by worse PROMs, but not by standard laboratory measures of disease activity. Patients with RF negative RA had worse disability, likely reflecting distinct factors influencing PROMs in this subgroup.   

 

             

Disclosure: T. Hansson, None; C. Book, None; L. T. H. Jacobsson, None; C. Turesson, None.

To cite this abstract in AMA style:

Hansson T, Book C, Jacobsson LTH, Turesson C. Disability in Early Rheumatoid Arthritis, Course and Predictors   [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/disability-in-early-rheumatoid-arthritis-course-and-predictors/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disability-in-early-rheumatoid-arthritis-course-and-predictors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology